within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AA14_Lipegfilgrastim;

model Lipegfilgrastim
  extends Pharmacolibrary.Drugs.ATC.L.L03AA14;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L03AA14</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Lipegfilgrastim is a long-acting, glycoPEGylated recombinant human granulocyte colony-stimulating factor (G-CSF) analogue. It is used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adult patients undergoing cytotoxic chemotherapy. It is an approved drug in Europe, marketed mainly under the trade name Lonquex.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult cancer patients, both male and female, after a single subcutaneous dose of 6 mg lipegfilgrastim following cytotoxic chemotherapy.</p><h4>References</h4><ol><li><p>Yang, BB, &amp; Kido, A (2011). Pharmacokinetics and pharmacodynamics of pegfilgrastim. <i>Clinical pharmacokinetics</i> 50(5) 295–306. DOI:<a href=\"https://doi.org/10.2165/11586040-000000000-00000\">10.2165/11586040-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21456630/\">https://pubmed.ncbi.nlm.nih.gov/21456630</a></p></li><li><p>Buchner, A, et al., &amp; Bias, P (2014). Lipegfilgrastim: pharmacodynamics and pharmacokinetics for body-weight-adjusted and 6 mg fixed doses in two randomized studies in healthy volunteers. <i>Current medical research and opinion</i> 30(12) 2523–2533. DOI:<a href=\"https://doi.org/10.1185/03007995.2014.962131\">10.1185/03007995.2014.962131</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25251999/\">https://pubmed.ncbi.nlm.nih.gov/25251999</a></p></li><li><p>Bedell, C (2003). Pegfilgrastim for chemotherapy-induced neutropenia. <i>Clinical journal of oncology nursing</i> 7(1) 55–64. DOI:<a href=\"https://doi.org/10.1188/03.CJON.55-56\">10.1188/03.CJON.55-56</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12629935/\">https://pubmed.ncbi.nlm.nih.gov/12629935</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Lipegfilgrastim;
